Literature DB >> 29812985

Remote control of glucose-sensing neurons to analyze glucose metabolism.

Alexandra Alvarsson1, Sarah A Stanley1,2.   

Abstract

The central nervous system relies on a continual supply of glucose, and must be able to detect glucose levels and regulate peripheral organ functions to ensure that its energy requirements are met. Specialized glucose-sensing neurons, first described half a century ago, use glucose as a signal and modulate their firing rates as glucose levels change. Glucose-excited neurons are activated by increasing glucose concentrations, while glucose-inhibited neurons increase their firing rate as glucose concentrations fall and decrease their firing rate as glucose concentrations rise. Glucose-sensing neurons are present in multiple brain regions and are highly expressed in hypothalamic regions, where they are involved in functions related to glucose homeostasis. However, the roles of glucose-sensing neurons in healthy and disease states remain poorly understood. Technologies that can rapidly and reversibly activate or inhibit defined neural populations provide invaluable tools to investigate how specific neural populations regulate metabolism and other physiological roles. Optogenetics has high temporal and spatial resolutions, requires implants for neural stimulation, and is suitable for modulating local neural populations. Chemogenetics, which requires injection of a synthetic ligand, can target both local and widespread populations. Radio- and magnetogenetics offer rapid neural activation in localized or widespread neural populations without the need for implants or injections. These tools will allow us to better understand glucose-sensing neurons and their metabolism-regulating circuits.

Entities:  

Keywords:  glucose; magnetogenetics; neuromodulation; radiogenetics

Mesh:

Substances:

Year:  2018        PMID: 29812985      PMCID: PMC6171010          DOI: 10.1152/ajpendo.00469.2017

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  175 in total

1.  Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ.

Authors:  Denis Burdakov; Oleg Gerasimenko; Alexei Verkhratsky
Journal:  J Neurosci       Date:  2005-03-02       Impact factor: 6.167

2.  Decreased glucokinase protein expression in the aged gerbil hippocampus.

Authors:  Choong Hyun Lee; Joon Ha Park; Moo-Ho Won
Journal:  Cell Mol Neurobiol       Date:  2013-03-21       Impact factor: 5.046

3.  Hypothalamic orexin-A-immunpositive neurons express Fos in response to central glucopenia.

Authors:  K P Briski; P W Sylvester
Journal:  Neuroreport       Date:  2001-03-05       Impact factor: 1.837

4.  Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K+ channels.

Authors:  M L Ashford; P R Boden; J M Treherne
Journal:  Pflugers Arch       Date:  1990-01       Impact factor: 3.657

5.  Hyperglycemic or feeding response to glucoprivation and hypothalamic glucoreceptors.

Authors:  E E Müller; A Pecile; D Cocchi; V R Olgiati
Journal:  Am J Physiol       Date:  1974-05

Review 6.  Metabolism of ketone bodies by the brain.

Authors:  L Sokoloff
Journal:  Annu Rev Med       Date:  1973       Impact factor: 13.739

7.  Knockdown of Neuropeptide Y in the Dorsomedial Hypothalamus Promotes Hepatic Insulin Sensitivity in Male Rats.

Authors:  Lin Li; C Barbier de La Serre; Ni Zhang; Liang Yang; Hong Li; Sheng Bi
Journal:  Endocrinology       Date:  2016-11-02       Impact factor: 4.736

8.  Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production.

Authors:  A Christine Könner; Ruth Janoschek; Leona Plum; Sabine D Jordan; Eva Rother; Xiaosong Ma; Chun Xu; Pablo Enriori; Brigitte Hampel; Gregory S Barsh; C Ronald Kahn; Michael A Cowley; Frances M Ashcroft; Jens C Brüning
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

9.  Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus.

Authors:  Donald A Morgan; Latisha N McDaniel; Terry Yin; Michael Khan; Jingwei Jiang; Michael R Acevedo; Susan A Walsh; Laura L Boles Ponto; Andrew W Norris; Michael Lutter; Kamal Rahmouni; Huxing Cui
Journal:  Diabetes       Date:  2015-01-20       Impact factor: 9.461

10.  Genetically targeted magnetic control of the nervous system.

Authors:  Michael A Wheeler; Cody J Smith; Matteo Ottolini; Bryan S Barker; Aarti M Purohit; Ryan M Grippo; Ronald P Gaykema; Anthony J Spano; Mark P Beenhakker; Sarah Kucenas; Manoj K Patel; Christopher D Deppmann; Ali D Güler
Journal:  Nat Neurosci       Date:  2016-03-07       Impact factor: 24.884

View more
  3 in total

1.  Multi-Electrode Array Analysis Identifies Complex Dopamine Responses and Glucose Sensing Properties of Substantia Nigra Neurons in Mouse Brain Slices.

Authors:  Nadja Mannal; Katharina Kleiner; Michael Fauler; Antonios Dougalis; Christina Poetschke; Birgit Liss
Journal:  Front Synaptic Neurosci       Date:  2021-02-26

Review 2.  Neuromodulation of metabolic functions: from pharmaceuticals to bioelectronics to biocircuits.

Authors:  Benjamin J Seicol; Sebastian Bejarano; Nicholas Behnke; Liang Guo
Journal:  J Biol Eng       Date:  2019-08-01       Impact factor: 4.355

Review 3.  Neonatal Hypoglycemia and Brain Vulnerability.

Authors:  Laura Costanza De Angelis; Giorgia Brigati; Giulia Polleri; Mariya Malova; Alessandro Parodi; Diego Minghetti; Andrea Rossi; Paolo Massirio; Cristina Traggiai; Mohamad Maghnie; Luca Antonio Ramenghi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-16       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.